Birmingham signs agreement with Chinese medical researchers

The University of Birmingham has signed an agreement with Wenzhou Medical University to explore new opportunities for working together on translational and allied health research. 

The President and the Director of Research & Development, of the 2nd Affiliated Hospital of WenZhou Medical University, located in Zhejiang province, south-east China, visited Birmingham. 

They discussed future collaboration, which may include perioperative, surgery, maternal, as well as research into the effects of aging. 

IMG_3353Professor Jon Frampton, Director of the China Institute and Deputy Pro Vice-Chancellor (China), signed the agreement with Professor Qingquan Lian, President of the Second Affiliated Hospital of Wenzhou Medical University - both pictured above. 

Professor Fang Gao, Professor in Anaesthesia, Critical Care and Pain at the University of Birmingham’s Institute of Inflammation and Ageing, organised the visit with support from the University’s China Institute. 

She said: “Following 13 year successful collaborations in translational and clinical research at the institute levels, we trust we can advance this further to a strong and productive partnership between two universities.” 

The visitors met a range of senior research experts from the University of Birmingham: Professor Peter Brocklehurst, Director of Birmingham Clinical Trials Unit (BCTU); Professor KK Chen, Director of Allied Health Research; Professor Dion Morton, Director of Birmingham Surgical Clinical Trial Consortium; Professor Subrata Gosh, Director of Institute of Translational Medicine (ITM); Professor Janet Lord, Director, Professor Chris Buckley, Deputy Director and Professor David Thickett, of the Institute of Inflammation and Ageing; Dr Liz Sapey, manager director, Centre of Translational Inflammation Research.   

Professor Jon Frampton said: “The University of Birmingham has a growing reputation in China. This is another opportunity for our researchers to work with their Chinese peers. As a global ‘civic’ university, our duty is to enrich the life of our home city and the wider world.” 

The visit saw delegates and Birmingham experts also discussed future collaboration on a range of other clinical trials, including anaesthesia, surgery and critical care. 

Wenzhou Medical University is an institution of higher learning under the leadership of Zhejiang Provincial Government. Its history can be traced back to Zhejiang Specialized Medical School established in Hangzhou in 1912. 

ENDS  

For more information, please contact Tony Moran, International Communications Manager, University of Birmingham on +44 (0) 121 414 8254 or  +44 (0)782 783 2312. For out of hours media enquiries, please call: +44 (0) 7789 921 165.

Notes to Editors 

  • The University of Birmingham is ranked in the world’s top 100 institutions, its work brings people from across the world to Birmingham, including researchers and teachers and more than 5,000 international students from over 150 countries. 
  • The China Institute is a central hub for Chinese interests at the University of Birmingham. It brings together people, ideas, funding, research and academic excellence to help create opportunities to work in partnership with China.